The Patent Finder

Italfarmaco S.p.A.

Also on record
Records under this name other than the patents Italfarmaco S.p.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.

Back to Italfarmaco S.p.A.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,273,730Use of estriol in low doses
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,835,414Treatment of vaginal atrophy in women with cardiovascular pathology risk
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,114,143Treatment of vaginal atrophy in women with tumor pathology risk
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,227,515Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments
Term ended
Term ended Apr 23, 2026 · USPTO record
Term endedTerm ended Apr 23, 2026USPTO record
US 8,637,702Derivatives of N-hydroxybenzamide for treating HIV infections
Lapsed on the fee record
Ended Jan 28, 2026 · USPTO record
Lapsed on the fee recordEnded Jan 28, 2026USPTO record
US 7,635,788Alpha-amino acid derivatives with antiinflammatory activity
Term ended
Term ended Dec 2, 2025 · USPTO record
Term endedTerm ended Dec 2, 2025USPTO record
US 7,329,689Monohydrate Hydrochloride of the 4-Hydroxycarbamoyl-PHENYL)-CARBAMIC Acid (6-Diethylaminomethyl-NAPHTALEN-2-YL) Ester
Term ended
Term ended Jan 15, 2024 · High confidence
Term endedTerm ended Jan 15, 2024High confidence
US 7,235,689Hydroxamic acid derivatives having anti-inflammatory action
Term ended
Term ended Jan 7, 2024 · USPTO record
Term endedTerm ended Jan 7, 2024USPTO record
US 7,157,099Sustained release pharmaceutical compositions for the parenteral administration of hydrophilic compounds
Term ended
Term ended Feb 1, 2023 · USPTO record
Term endedTerm ended Feb 1, 2023USPTO record
US 7,427,620Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes
Lapsed on the fee record
Ended Sep 23, 2020 · USPTO record
Lapsed on the fee recordEnded Sep 23, 2020USPTO record
10 of 41 patents shown.
Pro members see all 41.
Pro members: see all 41 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited